Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03596866
Title A Study of Brigatinib Compared to Alectinib in Adults With Non-Small-Cell Lung Cancer (ALTA-3)
Acronym ALTA-3
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Takeda
Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU | CAN | AUT

Additional content available in CKB BOOST